Biomarkers and New Treatment Target in Ankylosing Spondylitis Chou, Chung-Tei, M.D. Professor of Medicine, Division of AllergyImmunology-Rheumatology Veterans General Hospital, Taipei, Taiwan 1

First Page		Document Content
Date: 2014-04-24 21:01:08 Arthritis Autoimmune diseases Soft tissue disorders Musculoskeletal disorders Ankylosing spondylitis Spondyloarthropathy Psoriatic arthritis Reactive arthritis Enthesitis Medicine Health Rheumatology		Biomarkers and New Treatment Target in Ankylosing Spondylitis Chou, Chung-Tei, M.D. Professor of Medicine, Division of AllergyImmunology-Rheumatology Veterans General Hospital, Taipei, Taiwan 1 Add to Reading List Source URL: aplarcongress.org Download Document from Source Website File Size: 2,38 MB Share Document on Facebook

$Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1277 Spinal fractures related to ankylosing spondylitis Epidemiology, clinical outcome and biomechanics$	Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1277 Spinal fractures related to ankylosing spondylitis Epidemiology, clinical outcome and biomechanics DocID: 1t0Go - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1p0mJ - View Document
	Ankylosing Spondylitis Testing found more than six times the expected amount of Lead in the patient’s body along with other harmful toxic metals that carry a long list of side effects and slow the healing process! In DocID: 1kiaM - View Document
	Toll- FreeFaxFax Referral Form MotherToBaby Studies conducted by OTIS Patient’s Name: ______________________________________________________________________________________________ Patie DocID: 1ftS6 - View Document
	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 www.novartis.ca http://www.novartis.com DocID: 19IHX - View Document